Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
PLoS ONE 13 , e0191819 (2018)
October 2024 The GLP-1 receptor agonist drug class has revolutionized obesity treatment, and has spurred investment and innovation across the pharmaceutical industry
December 2025 brought additional milestones with global implications
Just as important, I want to figure out how to make that work in real primary care and weight-management workflow, then share what I learn with other clinicians so they can provide better care too
Diabetologia 20 , 8793 (1981)
US$ 29.85
US$ 24.82
US$ 25.40
